Envestnet Asset Management Inc Roivant Sciences Ltd. Transaction History
Envestnet Asset Management Inc
- $324 Billion
- Q3 2025
A detailed history of Envestnet Asset Management Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 38,289 shares of ROIV stock, worth $776,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,289
Previous 42,810
10.56%
Holding current value
$776,883
Previous $482,000
20.12%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
397Shares Held
464MCall Options Held
6.03MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA42.1MShares$853 Million0.01% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...